(Alliance News) - Garofalo Health Care Spa reported Thursday that it reported revenues up 32 percent year-on-year for the nine months, to EUR347.3 million from EUR263.1 million in the same period last year.
This higher output was driven by an increase in services provided to private and Out-of-Region patients, up 8 percent and 7 percent, respectively, compared to the nine months of 2023, "confirming the attractiveness of the group's facilities and the growing demand for healthcare services," as well as an increase in services provided to regional patients under agreement with the NHS, following the receipt of extra-budgets allocated by some regions and aimed mainly at reducing waiting lists.
Adjusted Ebitda improved to EUR58.9 million from EUR51.0 million or 16 percent, with a margin on sales of 17.0 percent. Operating income, on the other hand, rose to EUR36.9 million from EUR32.1 million in the previous year.
Net income rose slightly to EUR18.7 million from EUR18.4 million.
Net financial position increased to EUR195.4 million from EUR205.7 million. Capital expenditures incurred in the nine months amounted to EUR12.5 million.
Garofalo Health Care's stock closed Thursday up 2.5 percent to EUR5.72 per share.
By Giuseppe Fabio Ciccomascolo, Alliance News senior reporter
Comments and questions to redazione@alliancenews.com
Copyright 2024 Alliance News IS Italian Service Ltd. All rights reserved.
